Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine
Not Applicable
Withdrawn
- Conditions
- Migraine
- Interventions
- Device: Relivion®
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT05804396
The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)
Not Applicable
Completed
- Conditions
- MDD
- Interventions
- Device: Relivion®DP- ShamDevice: Relivion®DP- Active
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 126
- Registration Number
- NCT04279522
- Locations
- 🇺🇸
Kadima Neuropsychiatry Institute, La Jolla, California, United States
🇺🇸UCLA Semel Institute for Neuroscience and Behaviour, Los Angeles, California, United States
🇺🇸San Marcus Research Clinic, Miami Lakes, Florida, United States
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Not Applicable
Completed
- Conditions
- Acute Migraine
- Interventions
- Device: Relivion activeDevice: Relivion Sham
- First Posted Date
- 2018-08-15
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 187
- Registration Number
- NCT03631550
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸Clinical Research Consortium, an AMR company, Las Vegas, Nevada, United States
🇺🇸Hartford HealthCare Headache Center, Hartford, Connecticut, United States
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
Not Applicable
Completed
- Conditions
- Migraine
- Interventions
- Device: Relievion device- Treatment stimulationDevice: Relievion Device- Sham stimulation
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT03398668
- Locations
- 🇮🇱
Laniado Medcial Center, Netanya, Israel
A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.
Not Applicable
Terminated
- Conditions
- Migraine
- Interventions
- Device: Relievion Device- Treatment StimulationDevice: Relievion Device- Sham stimulation
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT03185559
- Locations
- 🇮🇱
Meir General Hospital, Kfar Saba, Israel
Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Neurolief system
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT02805881
- Locations
- 🇮🇱
Beer- Yakov Nees-Ziona Mental Health Center, Ness Ziona, Israel
Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain
Not Applicable
Completed
- Conditions
- Headache, Migraine
- Interventions
- Device: OSTNS NeurostimulatorDevice: Placebo OSTNS Neurostimulator
- First Posted Date
- 2015-05-08
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Neurolief Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT02438553
- Locations
- 🇮🇱
Meir General Hospital, Kfar Saba, Israel
© Copyright 2025. All Rights Reserved by MedPath